Changing regulations are reshaping the practice of oncology. Issues such as prior authorization, shifting coverage policies, reporting mandates, and reimbursement certainty all affect how clinics must operate to provide the best care. In this episode, CANCER BUZZ speaks with 3 oncology professionals, representing different roles and regions of the country, about their experiences of how policy impacts care delivery. Martin Palmeri, MD, MBA, FASCO, medical oncologist at Messino Cancer Centers, Patricia Serna, MHS, PA-C, CGRA, APP area manager at Texas Oncology, and Gretchen Van Dyck, financial counselor at Green Bay Oncology, connect the dots between legislative intents and clinical realities.

"When my patients see that their options for clinical trials are diminishing, or some of these clinical trials are shutting down, they lose hope." - Martin Palmeri, MD, MBA, FASCO

"Being able to work with the Texas Society of Clinical Oncology has given me that behind-the-scenes background of if we don't speak up, our patients are going to suffer." Patricia Serna, MHS, PA-C, CGRA

Guests: Patricia Serna, MHS, PA-C, CGRA APP Area Manager – APP Services Texas Oncology Dallas, TX

Gretchen Van Dyck Financial Counselor II Green Bay Oncology Green Bay, WI

Martin Palmeri, MD, MBA, FASCO Medical Oncologist Messino Cancer Centers Asheville, NC

This podcast is part of the Oncology State Societies (OSS) Advocacy Engagement program, made possible with support from Johnson & Johnson.

Resources:

• ACCC Advocacy Resources

• Access, Payment & Reimbursement Reform

• ACCC Community Oncology Research Institute (ACORI)